Dallas, TXNCT05861895Now EnrollingIRB Ready

Solid Tumors, Adult Clinical Trial in Dallas, TX

Access cutting-edge solid tumors, adult treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by HighField Biopharmaceuticals Corporation

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access solid tumors, adult specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors, adult treatment provided free

Apply for This Dallas Location

Check if you qualify for this solid tumors, adult clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Solid Tumors, Adult Study in Dallas

HF158K1 is an investigational liposome form of doxorubicin hydrochloride, an anthracycline topoisomerase inhibitor, encapsulated by lipid membranes containing TL01, a HER2-directed Trastuzumab Fab fragment conjugated lipid.

Sponsor: HighField Biopharmaceuticals Corporation

Who Can Participate

Inclusion Criteria

Voluntary to participate and sign ICF.
Age ≥ 18 and ≤ 75 years.
Unresectable or metastatic advanced solid tumors with HER-2 expression (IHC 3+, 2+, or 1+).
ECOG score 0-1.
Expected survival ≥ 6 months.
At least one measurable lesion per RECIST v1.1.
Adequate organ function: ANC ≥ 1.5×10⁹/L, LYM ≥ 1.0×10⁹/L, PLT ≥ 90×10⁹/L, HGB ≥ 8.0 g/dL; APTT ≤ 1.5×ULN, INR ≤ 1.5; TBIL ≤ 1.5×ULN, ALT/AST ≤ 2.5×ULN (≤ 5×ULN if liver metastases); CrCl ≥ 30 mL/min; LVEF ≥ 50%.
Agreement to use effective contraception.

Exclusion Criteria

Cumulative doxorubicin dose ≥ 350 mg/m² or prior anthracycline-induced cardiotoxicity.
Current use of immunosuppressants or systemic corticosteroids (\> 10 mg/day prednisone).
Prior anti-tumor therapy \< 2 weeks (4 weeks for nitrosourea/mitomycin C).
Symptomatic CNS metastases.
Unresolved AEs from prior therapy \> Grade 1.
Serious cardiovascular diseases (thromboembolic events within 3 months, NYHA III-IV, ACS within 6 months, or uncontrolled hypertension).
Active infection or unexplained fever \> 38.5°C.
HIV, active HBV or HCV.
Pregnant or breastfeeding.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT05861895) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors, Adult Treatment Options in Dallas, TX

If you're searching for solid tumors, adult treatment options in Dallas, TX, this clinical trial (NCT05861895) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors, adult specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors, adult clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Dallas, TX

See all advanced solid tumors clinical trials recruiting in Dallas — not just this study.

Browse Advanced Solid Tumors Trials in Dallas →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX